- May 02, 2024Source: Salud America
7 Things You Should Know About Brain Tumors
- May 02, 2024Source: Science Magazine
Study finds private equity expanding to mental health facilities
- May 01, 2024Source: WebMD
New 'FLiRT' Variants Spark Summer COVID Surge Warning
- May 01, 2024Source: News Africa
Yale HRL report: ‘11 more North Darfur villages razed by arson’
- May 01, 2024Source: Yale News
Understanding Youth Nicotine Use to Prevent Initiation and Escalation
- April 30, 2024Source: CNN
EPA implements toughest restrictions yet on use of highly toxic chemical in paint stripper
- April 30, 2024
Amid Opioid Overdose Crisis, Yale Program in Addiction Medicine Advises State on Drug Company Settlement Spending
- April 26, 2024Source: The New Arab
Thousands could die as Rapid Support Forces close in Al-Fashir in Sudan's Darfur province
Meet Some of Our Faculty
Assistant Professor of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health
Dr. Bei’s research interests in Plasmodium – the causative agent of malaria - lie at the intersection between population genetics, genomics, molecular genetics, epidemiology, and immunology. Her current research uses a translational systems biology approach to study the impact of antigenic diversity on immune evasion, transmission, and virulence in setting of declining malaria transmission. She is studying the development of genotype-specific and genotype-transcendent immunity and assess the effect of specific persisting genotypes on neutralizing humoral immune responses and their transmission potential in the mosquito vector. She also works on malaria vaccine candidate discovery and validation, studying the functional consequences of naturally arising diversity. Dr. Bei has ongoing research projects in Senegal in addition to many active collaborations in Sub-Saharan African countries in both East and West Africa.Associate Professor of Public Health (Health Policy), Associate Professor of Economics, and Associate Professor in the Institution for Social and Policy Studies
Zack Cooper is an Associate Professor of Public Health and Associate Professor of Economics at Yale University. He also serves as Director of Health Policy at Yale's Institution for Social and Policy Studies. Professor Cooper is a health economist whose work is focused on producing data-driven scholarship that can inform public policy. In his academic work, he has analyzed the impact of competition in hospital and insurance markets, studied the influence of price transparency on consumer behavior, investigated the causes of surprise out-of-network bills, and examined the influence of electoral politics on health care spending growth. Cooper has published his research in leading economics and medical journals including the Quarterly Journal of Economics and the New England Journal of Medicine. He has also presented his research at the White House, the Department of Justice, the Federal Trade Commission, and the Department of Health and Human Services. In January 2021, Zack Cooper and Fiona Scott Morton launched the 1% Steps for Health Care Reform project. The aim of the project is harness the power of rigorous economic scholarship to identify tangible steps that can be taken to reduce health care spending in the US without harming quality. The project includes 16 briefs written by leading economists that describe 16 specific interventions, which would collectively lower health care costs in the US by approximately $400 billion annually. You can hear a description of the project on the Freakenomics Podcast (Part 1and Part 2). Cooper received his undergraduate degree from the University of Chicago and his PhD from the London School of Economics, where he received the Richard Titmuss prize for Best PhD thesis. He was an Economic and Social Science Research Council Postdoctoral Fellow in economics at the LSE’s Centre for Economic Performance where he remains a Faculty Associate. Cooper is a Faculty Research Fellow at the National Bureau of Economic Research and a 2019 winner of and Andrew Carnegie Fellowship from the Carnegie Corporation of New York. His research on health care spending on the privately insured can be found at: healthcarepricingproject.org.Professor of Epidemiology (Chronic Diseases); Co-Leader, Cancer Prevention and Control
Dr. Ma is Professor of Epidemiology at the Yale School of Public Health, and Co-Leader of the Cancer Prevention and Control Research Program at the Yale Comprehensive Cancer Center, Yale School of Medicine. She studies the etiology and health outcomes of different types of cancer, with a focus on pediatric cancer and malignancies of the hematopoietic system (e.g., leukemia, lymphoma, myelodysplastic syndromes, and myeloproliferative neoplasms). Her research has addressed the impact of immunological factors, chemical exposures, and genetic characteristics on the risk of cancer. In addition, she has assessed the patterns of care and cost implications of cancer screening and treatment in older adults.
More than 75% of the population of
the nation’s most vulnerable neighborhoods identified with heat-related disparities.
Over 200 active grants
are currently funded to support our innovative and collaborative research.
74% of alumni have engaged with
YSPH students by volunteering, joining events, donating, and other activities.
Your future in public health begins with YSPH...
Upcoming Events
May 202420All Day
- School OnlyFEATUREDAll Day
May 20243Tomorrow
School Only Yale Only Kate Nyhan, MLSEveryone Divya Balaji KamerkaYale Only Kayla Del Biondo - Kate Nyhan, MLS
May 20244Saturday
Everyone Elizabeth Claus, PhD, MD - Jose DeJesus - Mathew Krick, BS, MPH - Tony Rentas